Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Sevofluran (ATC-Code: N01AB08).

Conclusion of a non-exclusive rebate contract under § 130a Paragraph 8 SGB V for the prescription and dispensing of medicinal products with the active substance Sevoflurane (ATC Code: N01AB08) required in the course of outpatient care in Lower Saxony, for the period from 01.07.2026 to 30.06.2028, with the possibility of concluding the contract at any time during the term ("open-house model"). In Lower Saxony, pharmacies must prioritise finished medicinal products for which a rebate contract under § 130a Paragraph 8 SGB V exists, for dispensing in the course of outpatient care, from 01.07.2026.